Highlights and Quick Summary
- Treasury Stock for the quarter ending March 31, 2019 was $0 (a NaN% decrease compared to previous quarter)
Visit stockrow.com/BCEL
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Treasury Stock of Atreca, Inc.
Most recent Treasury Stockof BCEL including historical data for past 10 years.Interactive Chart of Treasury Stock of Atreca, Inc.
Atreca, Inc. Treasury Stock for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2019 | – | – | – | $0.0 | – |
| 2018 | $0.0 | $0.0 | – | – | – |
Business Profile of Atreca, Inc.
Sector: Healthcare
Industry: Biotechnology